Search research articles
Contact Us
Filters
Showing results (81-90 of 93) with videos related to
Page
of 10
Sort By:
Vaccines
|
November 27, 2021
Reactogenicity of BNT162b2 mRNA COVID-19 Vaccine in a Young Working Age Population: A Survey among Medical School Residents, within a Mass Vaccination Campaign, in a Regional Reference Teaching Hospital in Italy
Alborz Rahmani, Guglielmo Dini, Andrea Orsi, et al.
Vaccines
|
December 3, 2020
Attitudes and Beliefs on Influenza Vaccination during the COVID-19 Pandemic: Results from a Representative Italian Survey
Alexander Domnich, Maura Cambiaggi, Alessandro Vasco, et al.
Expert Review of Vaccines
|
June 13, 2024
Mapping and ranking outcomes for the evaluation of seasonal influenza vaccine efficacy and effectiveness: a delphi study
Chiara de Waure, Elisabetta Alti, Vincenzo Baldo, et al.
Vaccines
|
January 21, 2023
Surveillance of Severe Acute Respiratory Infection and Influenza Vaccine Effectiveness among Hospitalized Italian Adults, 2021/22 Season
Donatella Panatto, Alexander Domnich, Maria Chironna, et al.
Journal of Infection and Public Health
|
January 18, 2025
Exploring case definitions and the natural history of respiratory syncytial virus in adult outpatients: First-season results of the RESPIRA-50 study
Alexander Domnich, Francesco Lapi, Andrea Orsi, et al.
Microorganisms
|
January 21, 2023
Prevalence of Pneumococcal Serotypes in Community-Acquired Pneumonia among Older Adults in Italy: A Multicenter Cohort Study
Andrea Orsi, Alexander Domnich, Stefano Mosca, et al.
Infectious Diseases and Therapy
|
August 2, 2025
A Cluster Randomized Study to Explore Case Definitions, Clinical Course and Consequences of RSV in Community-Dwelling Adults Aged ≥ 50 Years
Alexander Domnich, Francesco Lapi, Andrea Orsi, et al.
Journal of Preventive Medicine and Hygiene
|
April 20, 2026
Giovanna Elisa Calabrò, Caterina Rizzo, Vincenzo Baldo, et al.
Cell Reports
|
June 21, 2025
Biological modifications of the immune response to COVID-19 vaccine in patients treated with rituximab and immune checkpoint inhibitors
Francesco Ravera, Martina Dameri, Isabella Lombardo, et al.
Journal of Preventive Medicine and Hygiene
|
April 10, 2023
[Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra<sup>®</sup> 2.0]
Giovanna Elisa Calabrò, Sara Boccalini, Angela Bechini, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 93) with videos related to
Sort By:
Page
of 10
Vaccines
|
November 27, 2021
Reactogenicity of BNT162b2 mRNA COVID-19 Vaccine in a Young Working Age Population: A Survey among Medical School Residents, within a Mass Vaccination Campaign, in a Regional Reference Teaching Hospital in Italy
Alborz Rahmani, Guglielmo Dini, Andrea Orsi, et al.
Vaccines
|
December 3, 2020
Attitudes and Beliefs on Influenza Vaccination during the COVID-19 Pandemic: Results from a Representative Italian Survey
Alexander Domnich, Maura Cambiaggi, Alessandro Vasco, et al.
Expert Review of Vaccines
|
June 13, 2024
Mapping and ranking outcomes for the evaluation of seasonal influenza vaccine efficacy and effectiveness: a delphi study
Chiara de Waure, Elisabetta Alti, Vincenzo Baldo, et al.
Vaccines
|
January 21, 2023
Surveillance of Severe Acute Respiratory Infection and Influenza Vaccine Effectiveness among Hospitalized Italian Adults, 2021/22 Season
Donatella Panatto, Alexander Domnich, Maria Chironna, et al.
Journal of Infection and Public Health
|
January 18, 2025
Exploring case definitions and the natural history of respiratory syncytial virus in adult outpatients: First-season results of the RESPIRA-50 study
Alexander Domnich, Francesco Lapi, Andrea Orsi, et al.
Microorganisms
|
January 21, 2023
Prevalence of Pneumococcal Serotypes in Community-Acquired Pneumonia among Older Adults in Italy: A Multicenter Cohort Study
Andrea Orsi, Alexander Domnich, Stefano Mosca, et al.
Infectious Diseases and Therapy
|
August 2, 2025
A Cluster Randomized Study to Explore Case Definitions, Clinical Course and Consequences of RSV in Community-Dwelling Adults Aged ≥ 50 Years
Alexander Domnich, Francesco Lapi, Andrea Orsi, et al.
Journal of Preventive Medicine and Hygiene
|
April 20, 2026
Giovanna Elisa Calabrò, Caterina Rizzo, Vincenzo Baldo, et al.
Cell Reports
|
June 21, 2025
Biological modifications of the immune response to COVID-19 vaccine in patients treated with rituximab and immune checkpoint inhibitors
Francesco Ravera, Martina Dameri, Isabella Lombardo, et al.
Journal of Preventive Medicine and Hygiene
|
April 10, 2023
[Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra<sup>®</sup> 2.0]
Giovanna Elisa Calabrò, Sara Boccalini, Angela Bechini, et al.
Page
of 10